Calhoun OTC Boosters Corp (EIN 884014457) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Tax Period

2024-01-01 to 2024-12-31

Calhoun OTC Boosters Corp, founded in 2022, is a micro nonprofit in the Youth Development sector that reported $52K in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $48K left a modest 6% surplus.

Mission

The purpose of the OTC "On Tour Company" program is to help enrich and educate students, as well as, entertain our community by providing superior theater experiences. Part of the mission is for the students to inspire, celebrate, and enhance understanding of themselves and others through the shared experience of live theater by acting in and producing: improvisation shows, Shakespeare plays, musicals, and classics. This is marked through innovative interpretations, reflection, and inclusion of our community and the world in which we live.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $51,583

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $51,583

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $7,668

Program Expenses $30,508

Other Expenses $48,413

TOTAL EXPENSES $48,413

Year-over-Year Comparison

	2024	2023	Change
Revenue	$51,583	$42,622	+0.2%
Expenses	$48,413	$46,013	+0.1%
Net Income	$3,170	$-3,391	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✓ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Lisa Leicht	Vice President	Director	$0	$0	$0
Iris Lapidius	Secretary	Director	$0	$0	$0
Carrie Levine	President	Director	$0	$0	$0
Helene Hibshman-Pino	Treasurer	Officer	$0	$0	$0
Daniel Logvin	President	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$51,583	$48,413	$10,467	$3,170
2023	$42,622	$46,013	$7,297	$-3,391
2022	$20,987	$10,299	$10,688	$10,688

Calhoun OTC Boosters Corp